Pictures from the Launch of Hope for Women International Cancer Center Celebrated at

Mamba Point Hotel Banquet Hall and the Hope for Women International Cancer Center

Held at the H.W.I. C. Center, A.B. Tolbert Road, Paynesville

Friday - Saturday, October 12 - 13, 2012

Foundation Chairman Massaqoui Kamara & Trustee Jeanne Juste

Lonestar Cell Foundation Supports Cancer Treatment in Liberia with Major Grant to Hope for Women International, Inc.

With an initial grant of $40,000 to enable early cancer detection, Lonestar Cell Foundation inaugurated its healthcare portfolio and celebrated the opening of Hope for Women International, Inc. (HFWI). The center was launched at a special reception on Friday, October 12, 2012, followed by a ribbon cutting ceremony and tour of the Paynesville facilities on Saturday, October 13. The Foundation joined the Liberian Cancer Society Reactivation Committee, Mt. Sinai Hospital, and other supporters and guests to celebrate Liberia’s first cancer prevention and treatment center.

Worldwide, cervical cancer is the second most common cancer in women, causing the death of one woman every two minutes. Although the disease is very preventable through early diagnosis, the devastating reality is that in developing countries like Liberia, at-risk women are not able to access services that could save their lives, leading to 424,000 new cervical cancer cases every year.

Lonestar Cell Foundation was established to promote the welfare, well-being and development of Liberian institutions, communities and citizens and realizes this goal through investments in Liberia’s education and healthcare sectors. In health and social welfare the Foundation directs resources towards the critical issue of access and service delivery, and funds initiatives that provide modern and relevant treatment options and quality care. HFWI provides cervical cancer screening and treatment; conducts cancer education and advocacy activities; and offers patient and family counseling to people whose lives have been touched by gynecologic and breast cancers.

Home / Next